195 related articles for article (PubMed ID: 10998223)
1. Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome.
Lopes EP; Granato CH; Lanzoni V; Granero L; Paranhos-Baccala G; Tomiyama H; Silva AE; Ferraz ML
Mem Inst Oswaldo Cruz; 2000; 95(5):717-20. PubMed ID: 10998223
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
5. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
Komatsu F; Takasaki K
Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
[TBL] [Abstract][Full Text] [Related]
6. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.
Yeh CT; Han CM; Lo SY; Ou JH; Fan KD; Sheen IS; Chu CM; Liaw YF
J Clin Microbiol; 1994 Sep; 32(9):2235-41. PubMed ID: 7529251
[TBL] [Abstract][Full Text] [Related]
7. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
8. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.
Gaudy C; Thevenas C; Tichet J; Mariotte N; Goudeau A; Dubois F
J Clin Microbiol; 2005 Apr; 43(4):1722-6. PubMed ID: 15814991
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
[TBL] [Abstract][Full Text] [Related]
12. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
14. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
15. IgM antibody response to the hepatitis C virus core protein in intravenous drug users.
Toniutto P; Falleti E; Gasparini V; Fabris C; Tisminetzky SG; Lombardelli T; Pacco P; Satta A; Pirisi M
Diagn Microbiol Infect Dis; 1999 Feb; 33(2):69-73. PubMed ID: 10091028
[TBL] [Abstract][Full Text] [Related]
16. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
Myrmel H; Navaratnam V; Asjø B
J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatitis C virus sequences in posttransfusion non-A, non-B hepatitis.
Shibata M; Morishima T; Kudo T; Maki T; Maki S; Nagai Y
Blood; 1991 Mar; 77(6):1157-60. PubMed ID: 1705830
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies to different virus antigens in patients with chronic hepatitis C].
Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
